Upregulated PXDNL promotes invasive breast carcinoma progression
- Xianping Zhou 1,2, Yanqiu Zhang 3, Baoyu Huang 4, Xiufang Shi 5, Maohong Bian 1
- Xianping Zhou 1,2, Yanqiu Zhang 3, Baoyu Huang 4
- 1Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, The People's Republic of China.
- 2Department of Blood Transfusion, The People's Hospital of Bozhou Bozhou, Anhui, The People's Republic of China.
- 3Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine Hefei, Anhui, The People's Republic of China.
- 4Department of Gastrointestinal Surgery, The People's Hospital of Bozhou Bozhou, Anhui, The People's Republic of China.
- 5Department of Clinical Laboratory, The People's Hospital of Bozhou Bozhou, Anhui, The People's Republic of China.
- 0Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, The People's Republic of China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.High peroxidase-like (PXDNL) expression in breast cancer is linked to poorer survival and reduced immune cell infiltration. PXDNL may serve as a prognostic biomarker or therapeutic target for invasive breast carcinoma.
Area Of Science
- Oncology
- Immunology
- Genomics
Background
- Invasive breast carcinoma (BRCA) is a significant health concern for women worldwide.
- The role of peroxidase-like (PXDNL) in BRCA progression remains largely undefined, despite its association with poor prognosis in other cancers.
Purpose Of The Study
- To investigate the potential carcinogenic role of PXDNL in invasive breast carcinoma.
- To analyze the correlation of PXDNL expression with prognosis, immune cell infiltration, and related biological pathways in BRCA.
Main Methods
- Utilized bioinformatic analysis of datasets from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and UALCAN.
- Examined PXDNL expression, promoter methylation, immune cell infiltration, immune checkpoint genes, and pathway enrichment.
Main Results
- PXDNL expression was significantly altered in BRCA, correlating with poorer survival across subtypes.
- High PXDNL expression was associated with reduced infiltration of various immune cells, including CD8+ T cells and NK cells.
- PXDNL expression correlated with immune checkpoint genes and modulated key pathways like epithelial-mesenchymal transition and inflammatory signaling.
Conclusions
- Overexpressed PXDNL is linked to unfavorable prognosis and altered immune microenvironment in BRCA.
- PXDNL presents potential as a prognostic biomarker and a therapeutic target for invasive breast carcinoma.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
02:07
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

